You are using an outdated browser. Please upgrade your browser to improve your experience.

methemoglobinemia due to deficiency of methemoglobin reductase

Disease Summary
Associated Targets (1)
Tbio

1


GARD Rare
Uniprot Description A form of methemoglobinemia, a hematologic disease characterized by the presence of excessive amounts of methemoglobin in blood cells, resulting in decreased oxygen carrying capacity of the blood, cyanosis and hypoxia. There are two types of methemoglobinemia CYB5R3-related. In type 1, the defect affects the soluble form of the enzyme, is restricted to red blood cells, and causes well-tolerated methemoglobinemia. In type 2, the defect affects both the soluble and microsomal forms of the enzyme and is thus generalized, affecting red cells, leukocytes and all body tissues. Type 2 methemoglobinemia is associated with mental deficiency and other neurologic symptoms.
Mondo Term and Equivalent IDs
MONDO:0009606:  methemoglobinemia due to deficiency of methemoglobin reductase
GARD:0003909: